top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Biomarkers and Biosensors for Cervical Cancer Diagnosis [[electronic resource] /] / edited by John Bosco Balaguru Rayappan, Jung Heon Lee
Biomarkers and Biosensors for Cervical Cancer Diagnosis [[electronic resource] /] / edited by John Bosco Balaguru Rayappan, Jung Heon Lee
Edizione [1st ed. 2021.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021
Descrizione fisica 1 online resource (IX, 115 p. 18 illus., 15 illus. in color.)
Disciplina 571.978
616.994
Soggetto topico Cancer
Tumor markers
Medical screening
Materials
Detectors
Cancer Biology
Tumour Biomarkers
Cancer Screening
Sensors and biosensors
Càncer de coll uterí
Biosensors
Marcadors bioquímics
Diagnòstic
Soggetto genere / forma Llibres electrònics
ISBN 981-16-2586-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. An Introduction to Cancer Biomarkers -- Chapter 2. Cervical Cancer -- Chapter 3. Potential Biomarkers for Early Diagnosis of Cervical Cancer -- Chapter 4. Methods for Screening of Cervical Cancer: State of Art -- Chapter 5. Electrochemical DNA Biosensors for Cervical Cancers -- Chapter 6. Optical DNA based Sensors for Cervical Cancers -- Chapter 7. Other Biosensors for Cervical Cancer Detection.
Record Nr. UNINA-9910495247203321
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers and genomic medicine
Biomarkers and genomic medicine
Pubbl/distr/stampa [Taiwan] : , : Elsevier Taiwan LLC, , 2013-
Descrizione fisica 1 online resource
Disciplina 576.5
Soggetto topico Genomics
Biochemical markers
Medicine
Biomarkers
Genòmica
Marcadors bioquímics
Soggetto genere / forma Periodical
Periodicals.
Revistes electròniques.
Soggetto non controllato Genetics
ISSN 2214-0255
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti BGM
Record Nr. UNISA-996210410103316
[Taiwan] : , : Elsevier Taiwan LLC, , 2013-
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Biomarkers and genomic medicine
Biomarkers and genomic medicine
Pubbl/distr/stampa [Taiwan] : , : Elsevier Taiwan LLC, , 2013-
Descrizione fisica 1 online resource
Disciplina 576.5
Soggetto topico Genomics
Biochemical markers
Medicine
Biomarkers
Genòmica
Marcadors bioquímics
Soggetto genere / forma Periodical
Periodicals.
Revistes electròniques.
Soggetto non controllato Genetics
ISSN 2214-0255
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti BGM
Record Nr. UNINA-9910333112903321
[Taiwan] : , : Elsevier Taiwan LLC, , 2013-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers in nutrition / / Vinood B. Patel and Victor R. Preedy
Biomarkers in nutrition / / Vinood B. Patel and Victor R. Preedy
Autore Patel Vinood B.
Pubbl/distr/stampa Cham, Switzerland : , : Springer International Publishing, , [2022]
Descrizione fisica 1 online resource (1173 pages)
Disciplina 610.28
Collana Biomarkers in Disease
Soggetto topico Biochemical markers
Biochemical markers - Evaluation
Marcadors bioquímics
Nutrició
Soggetto genere / forma Llibres electrònics
ISBN 3-031-07389-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910617306803321
Patel Vinood B.  
Cham, Switzerland : , : Springer International Publishing, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers of radiation in the environment : robust tools for risk assessment / / edited by Michael D. Wood [and three others]
Biomarkers of radiation in the environment : robust tools for risk assessment / / edited by Michael D. Wood [and three others]
Pubbl/distr/stampa Dordrecht, Netherlands : , : Springer, , [2022]
Descrizione fisica 1 online resource (333 pages)
Disciplina 610.28
Collana NATO Science for Peace and Security Series a: Chemistry and Biology
Soggetto topico Biochemical markers
Marcadors bioquímics
Soggetto genere / forma Llibres electrònics
ISBN 94-024-2101-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910558484403321
Dordrecht, Netherlands : , : Springer, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer biomarkers in diagnosis and therapeutics / / edited by Adeeb Shehzad
Cancer biomarkers in diagnosis and therapeutics / / edited by Adeeb Shehzad
Pubbl/distr/stampa Singapore : , : Springer, , [2022]
Descrizione fisica 1 online resource (372 pages)
Disciplina 616.994075
Soggetto topico Cancer - Diagnosis
Càncer
Marcadors bioquímics
Diagnòstic
Soggetto genere / forma Llibres electrònics
ISBN 981-16-5758-0
981-16-5759-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910743224703321
Singapore : , : Springer, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer stem cell markers and related network pathways / / edited by Shihori Tanabe
Cancer stem cell markers and related network pathways / / edited by Shihori Tanabe
Edizione [1st ed. 2022.]
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2023]
Descrizione fisica 1 online resource (163 pages)
Disciplina 610.28
Collana Advances in Experimental Medicine and Biology
Soggetto topico Biochemical markers
Stem cells
Cèl·lules mare
Marcadors bioquímics
Citodiagnòstic
Soggetto genere / forma Llibres electrònics
Soggetto non controllato Internal Medicine
Medical
ISBN 9783031129742
9783031129735
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1. Epithelial-mesenchymal transition and cancer stem cells -- 2. The transcription factors Zeb1 and Snail induce cell malignancy and can-cer stem cell phenotype in prostate cells, increasing androgen synthesis ca-pacity and therapy resistance -- 3. ERBB signaling pathway in cancer stem cells -- 4. Functional and molecular characters of cancer stem cells through devel-opment to establishment -- 5. Microenvironment in cancer stem cells -- 6. Cancer stem cells contribute to drug resistance in multiple different ways -- 7. Abnormal glycosylation in cancer cells and cancer stem cells as a thera-peutic target.
Record Nr. UNINA-9910639878103321
Cham, Switzerland : , : Springer, , [2023]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Identification of biomarkers, new treatments, and vaccines for COVID-19 / / Paul C. Guest, editor
Identification of biomarkers, new treatments, and vaccines for COVID-19 / / Paul C. Guest, editor
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2021]
Descrizione fisica 1 online resource (229 pages)
Disciplina 614.592414
Collana Advances in experimental medicine and biology
Soggetto topico COVID-19 (Disease)
COVID-19
Marcadors bioquímics
Terapèutica
Vacunes
Soggetto genere / forma Llibres electrònics
ISBN 3-030-71697-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Preface -- Contents -- Part I: Background -- 1: Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement -- 1 Introduction -- 2 Epidemiology -- 3 Main Coronavirus Groups -- 4 Genome, Genotype, and Protein Structure -- 5 Mechanism of Infection -- 6 COVID-19 Pathogenesis -- 7 Respiratory Manifestations -- 8 Extra-pulmonary Presentations -- 8.1 Gastrointestinal Manifestations -- 8.2 Cardiovascular Complications -- 8.3 Haematological Disorders -- 9 Immune Responses -- 10 Therapy -- 10.1 Drugs that Slow Viral Replication or Kill SARS-Cov-2 -- 10.2 Vaccination -- 11 Conclusion -- References -- Part II: Epidemiology -- 2: Prevalence of COVID-19 and the Continued Citizen-Based Control in Japan -- 1 Introduction -- 2 Cruise Ship Outbreak and the Environmental Assessment -- 2.1 COVID-19 Outbreak on the Diamond Princess Cruise Ship -- 2.2 Age-Related CFR Estimated from the Cruise Ship Outbreak -- 2.3 Environmental Assessment of SARS-CoV-2 on the Cruise Ship -- 3 Government-Recommended and Voluntary Measures to Protect Against COVID-19 Infection in Japan -- 4 Detection of the Coronavirus in Laboratories in Japan -- 5 Conclusions -- References -- 3: COVID-19 Pandemic in Brazil: History, Characteristics, and Evolution -- 1 Brief Historical Facts of the COVID-19 Pandemic in Brazil -- 2 Governmental Measures to Combat the Pandemic -- 3 Regional Characteristics Influencing the COVID-19 Dissemination -- 4 Prevalence of the Disease in Different Subpopulations -- 5 Concluding Remarks -- References -- 4: The Experiences of Recovered COVID-19 Patients in Baqiyatallah Hospital: A Qualitative Study -- 1 Introduction -- 2 Methods -- 2.1 Data Collection -- 2.2 Data Analysis -- 3 Results -- 3.1 Theme I: Emotional-Sensational-Paradox -- Satisfaction-Dissatisfaction -- Positive Experiences-Negative Experiences.
Relaxation-Stress -- Support-Rejection -- 3.2 Theme II: Spiritual Growth -- Accepting and Submitting to Divine Providence -- Rethinking Material Possessions -- Seeking Stronger Divine Connection -- Tendency to Spirituality -- 3.3 Theme III: Experienced Mental-Psychological Effects -- Unpleasant Thoughts -- Perceived Mental Stress -- Positive Thoughts -- 4 Discussion -- 5 Conclusions -- References -- Part III: Risk Factors and Outcomes -- 5: Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons -- 1 Introduction -- 2 Age-Related Effects of Different Infections -- 3 Age Effects of COVID-19 Disease -- 4 Clinical Features in Children -- 5 The Different Etiology and Severity of COVID-19 Based on Age -- 6 Underlying Conditions and Severity of COVID-19 in Children -- 7 Outdoor Activities and the Potential to Contract the Virus -- 8 Immune System and Age-Related Differences -- 9 Innate Immune Cells and Age-Related Differences -- 10 IFN-γ and SARS-CoV in Children -- 11 Adaptive Immune Response and Age-Related Difference -- 12 Cross-Protection Against SARS-CoV-2 and Age-Related Differences -- 13 Improved Efferocytosis by Bacillus Calmette-Guerin (BCG) Vaccine to Protect Against COVID-19 Pneumonia -- 14 Age-Related Difference and Higher Hemoglobin in COVID-19 Pneumonia -- 15 The Role of Sex Hormones and Age-Related Differences in COVID-19 -- 16 Interferon as a Target Therapy in Coronavirus Disease 2019 (COVID-19) -- 17 The Role of Lactoferrin in Immune System Age-Related Differences -- 18 The Recommendations for Selecting Treatment in Patients Based on Age and Neutrophil-to-Lymphocyte Ratio (NLR) -- 19 Conclusions -- References -- 6: Sex Differences and COVID-19 -- 1 Introduction -- 1.1 COVID-19 -- 1.2 Sex and the COVID-19 Response.
2 Physiological Sex Differences as Potential Moderators of COVID-19 Outcomes -- 2.1 The Immune System and COVID-19 -- 2.2 Sex Differences in the Immune System -- 2.3 Sex Hormones and the Immune Response -- 2.4 Sex Hormones and COVID-19 -- 2.5 Sex Chromosomes and the Immune System -- 2.6 Ageing, Sex and the Immune System -- 3 Sex Differences in the Renin-Angiotensin-Aldosterone System -- 3.1 Sex Differences in the Renin-Angiotensin System and COVID-19 -- 4 Reproduction, Pregnancy and COVID-19 -- 5 Long-Term Outcomes of COVID-19 and Sex Differences -- 6 Conclusion and Perspectives -- References -- 7: Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known? -- 1 Introduction -- 1.1 Epidemiological Characteristics of Coronavirus Diseases -- 1.2 Coronavirus Disease 2019 (COVID-19) -- 2 Microbiota and Respiratory Infection -- 3 Potential Connections Between Intestinal Microbiota and COVID-19 -- 3.1 Age Effects -- 3.2 Hypertension -- 3.3 Diabetes -- 3.4 Obesity -- 4 COVID-19 and Microbiota -- 5 Conclusions and Future Perspectives -- References -- 8: SARS-CoV-2 Infection and the Kidneys: An Evolving Picture -- 1 Introduction -- 2 Dialysis -- 3 Transplant -- 4 Chronic Kidney Disease -- 5 Apo L1 -- 6 The Clinical Picture of Kidney Disease in COVID-19 -- 6.1 Acute Kidney Injury Pathophysiology -- 7 Conclusions -- References -- 9: Cutaneous Manifestations of COVID-19: Early Diagnosis and Prognostic Information -- 1 Introduction -- 2 Exanthem Pattern -- 2.1 Vesicular Eruptions or Varicella-Like Exanthem -- 2.2 Maculopapular Eruptions or Maculopapular Rash -- 3 Urticarial Lesions -- 4 Vascular Pattern -- 4.1 Acral Areas of Erythema with Vesicles or Pustules (Pseudo-Chilblain) -- 4.2 Purpuric/Petechial Lesions -- 4.3 Livedo or Necrosis -- 5 Acro-Papular Eruption -- 6 Treatment -- 7 Pathophysiological Mechanisms.
8 Conclusions -- References -- 10: How Do We Manage Breastfeeding During the COVID-19 Pandemic? -- 1 Introduction -- 2 Benefits of Breastfeeding -- 3 COVID-19 and Breastfeeding: Current Evidence -- 4 Guidelines on Breastfeeding for Mothers with Suspected or Confirmed COVID-19 -- 5 Conditions Recommended for Starting and Maintaining Breastfeeding -- 6 Conditions in Which It Is Recommended to Extract Breast Milk -- 7 Conditions in Which Recommended for Not Breastfeeding or Extracting Breast Milk -- 8 Breastfeeding by Mothers Undergoing Medications for COVID-19 -- 9 Conclusions and Future Perspectives -- References -- 11: Deep Learning Analysis in Prediction of COVID-19 Infection Status Using Chest CT Scan Features -- 1 Introduction -- 2 Methods -- 2.1 Study Design and Participants -- 2.2 CT Examination and Image Analysis -- 2.3 Statistical Analysis -- Comparisons Between Two Groups -- Deep Learning Analyzing and Classification -- 3 Results -- 3.1 Demographic Characteristics and Chest CT Findings -- 3.2 Deep Learning Analyzing Results -- 4 Discussion -- 5 Conclusions -- References -- Part IV: Treatments and Vaccines -- 12: Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review -- 1 Introduction -- 2 Methods -- 2.1 Inclusion Criteria -- 2.2 Search Strategy -- 3 Results -- 3.1 Extraction of Results -- 3.2 Protocols -- 3.3 Mechanism of Ozone as a Treatment -- 3.4 Ozone Therapy and Viral Infections -- 3.5 Ozone Therapy and Respiratory System -- Asthma -- Chronic Obstructive Pulmonary Disease (COPD) -- Pulmonary Emphysema -- 4 Discussion -- 5 Conclusions and Future Perspective -- References -- 13: COVID-19, Coenzyme Q10 and Selenium -- 1 Introduction -- 2 CoQ10 -- 3 Selenium -- 4 Oxidative Stress, Inflammation and Virus Infection -- 4.1 Oxidative Stress -- 4.2 Inflammation.
5 Supplementation CoQ10 and Selenium -- 6 Conclusions and Future Perspectives -- References -- 14: Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19) -- 1 Introduction -- 2 Agents with Known Effect Against SARS-CoV-2 -- 2.1 Alcohol and Isopropanol -- 2.2 Povidone-Iodine -- 2.3 Hydrogen Peroxide -- 2.4 Ultraviolet (UV) Radiation -- 2.5 Xylitol -- 2.6 Brilacidin -- 2.7 Carrageenan -- 3 Agents with Potential Effect on SARS-CoV-2 -- 3.1 Acid-Buffered Saline -- 3.2 Hypertonic Saline -- 3.3 Oxymetazoline and Xylometazoline -- 3.4 Probiotics -- 3.5 Chlorhexidine -- 3.6 Citrox (Flavonoids) and Cyclodextrins -- 3.7 Cetylpyridinium Chloride (CPC) -- 3.8 Surfactants/Shampoo -- 3.9 Interferon -- 4 Therapeutic Application and Method of Delivery -- 5 Conclusions -- References -- 15: Cinnamon: A Promising Natural Product Against COVID-19 -- 1 Introduction -- 2 Antiallergic Properties -- 3 Antiviral Properties -- 4 Cardiovascular Properties -- 5 Safety of Cinnamon -- 6 Conclusions and Future Perspectives -- References -- 16: Curcumin and Piperine in COVID-19: A Promising Duo to the Rescue? -- 1 Introduction -- 2 Curcumin-Piperine -- 3 Curcumin-Piperine and Virus-Induced Lung Injury -- 4 Curcumin-Piperine and Thrombosis -- 5 Safety of Curcumin-Piperine -- 6 Conclusions and Future Perspectives -- References -- 17: Association of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19 -- 1 Introduction -- 2 Methods -- 2.1 Study Design and Participants -- 2.2 Data Collection -- 2.3 Medication -- 2.4 Outcomes -- 2.5 Statistical Analysis -- 3 Results -- 4 Discussion -- 5 Conclusion -- References -- 18: The Worldwide Effort to Develop Vaccines for COVID-19 -- 1 Introduction -- 2 The SARS-CoV-2 Spike Protein.
3 SARS-CoV-2 Vaccine Candidates in Phase 3 Clinical Trials.
Record Nr. UNINA-9910495243103321
Cham, Switzerland : , : Springer, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Multifaceted protocols in biotechnology . Volume 2 / / Azura Amid, editor
Multifaceted protocols in biotechnology . Volume 2 / / Azura Amid, editor
Edizione [1st ed. 2021.]
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2021]
Descrizione fisica 1 online resource (VII, 159 p. 45 illus., 32 illus. in color.)
Disciplina 660.6
Soggetto topico Biotechnology
Biochemical markers
Biotecnologia
Marcadors bioquímics
Soggetto genere / forma Llibres electrònics
ISBN 3-030-75579-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Graviola Fruit Extraction by Ionic Liquid Microwave-assisted Extraction (IL-MAE) -- Role of Ionic Liquids in the Enzyme Stabilization: A Case Study with Trichoderma ressie Cellulase -- Role of Ionic Liquids in the Processing of Lignocellulosic Biomass -- Proliferation of rat amniotic stem cell (AFSC) on modified surface microcarrier -- Application of spectroscopic methods for the analysis of non-halal meats in food products: A narrative review -- Identification of Potential Biomarkers of Porcine Gelatin -- Gamma Ray Mutagenesis on Bacteria Isolated from Shrimp Farm Mud for Microbial Fuel Cell Enhancement and Degradation of Organic Waste -- Effect of temperature on antibacterial activity and fatty acid methyl esters of Carica papaya seed extract -- Solid-state Fermentation of Agro-industrial Waste Using Heterofermentative Lacti Acid Bacteria -- Synthesis of chitosan-folic acid nanoparticles as a drug delivery system for propolis compounds.
Record Nr. UNINA-9910495207603321
Cham, Switzerland : , : Springer, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Saliva in Health and Disease [[electronic resource] ] : The Present and Future of a Unique Sample for Diagnosis / / edited by Asta Tvarijonaviciute, Silvia Martínez-Subiela, Pia López-Jornet, Elsa Lamy
Saliva in Health and Disease [[electronic resource] ] : The Present and Future of a Unique Sample for Diagnosis / / edited by Asta Tvarijonaviciute, Silvia Martínez-Subiela, Pia López-Jornet, Elsa Lamy
Edizione [1st ed. 2020.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020
Descrizione fisica 1 online resource (X, 326 p. 23 illus., 19 illus. in color.)
Disciplina 616.316
Soggetto topico Human physiology
Laboratory medicine
Pathology
Animal physiology
Human Physiology
Laboratory Medicine
Animal Physiology
Glàndules salivals
Marcadors bioquímics
Salut
Soggetto genere / forma Llibres electrònics
ISBN 3-030-37681-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Salivary glands' anatomy and physiology -- Saliva in ingestive behavior research: association with oral sensory perception and food intake -- Saliva - a non-invasive sample: Pros and Cons -- Methodology assays for the salivary biomarkers’ identification and measurement -- The role of saliva in dental practice -- Salivary biomarkers in respiratory diseases -- Salivary biomarkers in neurologic diseases -- Salivary biomarkers in the diagnosis and monitoring of metabolic and endocrine diseases -- Salivary markers in inflammatory and autoimmune diseases -- Salivary biomarkers in oral and systemic pathologies. Kidney diseases -- Salivary diagnosis of infectious diseases -- Salivary markers in systemic and oral cancer -- Saliva in sport sciences -- Salivary biomarkers in welfare studies -- The future of saliva as an analytical sample.
Record Nr. UNINA-9910409700603321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui